![]() ![]() is recalling eight lots of its 500 mg extended release metformin tablets ("APO-Metformin ER") because they contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) above the acceptable limit. The risks from not having adequate diabetes treatment outweigh any possible effects of exposure to the levels of nitrosamines found in the recalled Apotex metformin products.Īpotex Inc. You should not stop taking your medication without first discussing treatment options with your health care provider. recalls certain lots of the diabetes medication APO-Metformin ER (extended release) 500 mg tablets recalls certain lots of the diabetes medication APO-Metformin ER (extended release) 500 mg tabletsĪpotex Inc. Original Information Update: FebruApotex Inc. Please refer to the Affected products table below for detailed information on the recalled lots. The company is recalling an additional four lots (#AJY8005A, #AJY8005B, #AJY8008A and #AJZ8005A) as a precautionary measure because they contain NDMA close to the acceptable limit. Company testing identified two lots (#AJY8006A and #AJY8007A) with levels of NDMA above what is considered acceptable if the drug were to be taken over a lifetime. is recalling six lots of its prescription RAN-Metformin drug from the Canadian market. There are alternative metformin products on the Canadian market manufactured by other companies. ![]() NDMA test results are not available for this product this recall has been initiated because of the potential presence of nitrosamine impurities in the finished product. JAMP Pharma Corporation is voluntarily recalling all 26 lots of its prescription Metformin drug from the Canadian market (Metformin DIN 02380196 and Metformin DIN 02380218 ) as a precautionary measure. Should any additional recalls be necessary, Health Canada will update the table below and inform Canadians. As a precautionary measure, the company is also recalling eight other lots because levels of NDMA in those products may increase over time. Company test results showed one of the lots (PY7174) contains a nitrosamine impurity called N-nitrosodimethylamine (NDMA) that increased over time to a level above the acceptable limit. ![]() is voluntarily recalling nine additional lots of its prescription metformin drug, APO-METFORMIN ER (extended release) 500mg tablets. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |